Ultragenyx Pharmaceutical Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q3 2024.
  • Ultragenyx Pharmaceutical Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 95.5M shares, a 33.3% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 73.5M shares, a 5.19% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 69.9M shares, a 3.13% increase from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 67.8M shares, a 11.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 95.5M +23.8M +33.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 86.6M +15.7M +22.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 84.3M +13.9M +19.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 73.5M +3.63M +5.19% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 71.7M +1.61M +2.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 70.9M +973K +1.39% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 70.4M +852K +1.23% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 69.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 70.1M +2.18M +3.21% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 69.9M +2.32M +3.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 69.5M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q3 2021 67.9M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 67.6M +7.61M +12.7% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-03
Q2 2020 60M +2.48M +4.31% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q2 2019 57.5M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 53.2M +5.02M +10.4% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-07
Q1 2018 48.2M +6.35M +15.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q1 2017 41.8M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q2 2015 35.9M +5.88M +19.6% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-14
Q1 2015 34M +12.4M +57.6% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-12
Q4 2014 28.8M +25.2M +702% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 31.6M +28M +773% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-10
Q2 2014 30.1M +26.6M +758% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 21.6M +18.1M +524% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 3.58M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-26
Q3 2013 3.62M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 3.5M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 3.46M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.